Suppr超能文献

与肥胖相关的发病率和死亡率。

Morbidity and mortality associated with obesity.

作者信息

Abdelaal Mahmoud, le Roux Carel W, Docherty Neil G

机构信息

Diabetes Complications Research Centre, Conway Institute, School of Medicine and Medical Sciences, University College Dublin, Dublin, Ireland.

Plastic Surgery Department, Assiut University Hospital, Assiut, Egypt.

出版信息

Ann Transl Med. 2017 Apr;5(7):161. doi: 10.21037/atm.2017.03.107.

Abstract

Obesity and its repercussions constitute an important source of morbidity, impaired quality of life and its complications can have a major bearing on life expectancy. The present article summarizes the most important co-morbidities of obesity and their prevalence. Furthermore, it describes classification and grading systems that can be used to assess the individual and combined impact of co-morbid conditions on mortality risk. The literature was screened for assessment tools that can be deployed in the quantification of morbidity and mortality risk in individual patients. Thirteen specific domains have been identified that account for morbidity and mortality in obesity. Cardiovascular disease (CVD) and cancer account for the greatest mortality risk associated with obesity. The King's Criteria and Edmonton Obesity Staging System (EOSS) were identified as useful tools for the detection and monitoring of individual patient mortality risk in obesity care. The stark facts on the complications of obesity should be capitalized on to improve patient management and knowledge and referred to in the wider dissemination of public health messages aimed at improving primary prevention.

摘要

肥胖及其后果是发病的重要来源,生活质量受损,其并发症会对预期寿命产生重大影响。本文总结了肥胖最重要的合并症及其患病率。此外,还描述了可用于评估合并症对死亡风险的个体和综合影响的分类和分级系统。对文献进行筛选,以寻找可用于量化个体患者发病和死亡风险的评估工具。已确定了13个特定领域,这些领域与肥胖导致的发病和死亡有关。心血管疾病(CVD)和癌症是与肥胖相关的最大死亡风险因素。国王标准和埃德蒙顿肥胖分期系统(EOSS)被确定为肥胖护理中检测和监测个体患者死亡风险的有用工具。应利用肥胖并发症的严峻事实来改善患者管理和知识,并在更广泛传播旨在改善一级预防的公共卫生信息时提及这些事实。

相似文献

1
Morbidity and mortality associated with obesity.与肥胖相关的发病率和死亡率。
Ann Transl Med. 2017 Apr;5(7):161. doi: 10.21037/atm.2017.03.107.
2
Assessment of obesity beyond body mass index to determine benefit of treatment.超越体重指数评估肥胖以确定治疗益处。
Clin Obes. 2011 Apr;1(2-3):77-84. doi: 10.1111/j.1758-8111.2011.00017.x. Epub 2011 Jul 5.
5
9

引用本文的文献

8
Triple Agonism Based Therapies for Obesity.基于三重激动作用的肥胖症治疗方法
Curr Cardiovasc Risk Rep. 2025;19(1):18. doi: 10.1007/s12170-025-00770-z. Epub 2025 Jul 28.

本文引用的文献

1
Obesity Epidemiology Worldwide.全球肥胖流行病学
Gastroenterol Clin North Am. 2016 Dec;45(4):571-579. doi: 10.1016/j.gtc.2016.07.012.
8
Body mass index, diabetes, and triple-negative breast cancer prognosis.体重指数、糖尿病与三阴性乳腺癌预后
Breast Cancer Res Treat. 2014 Jul;146(1):189-97. doi: 10.1007/s10549-014-3002-y. Epub 2014 May 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验